Patients with ALK-positive (ALK+) non-small cell lung cancer (NSCLC) “frequently die of cancer-related causes, during hospitalization, and under active treatment,” underscoring the need for tailored palliative and end-of-life care approaches…
Cancer-Related Cause of Death and End-of-Life Management in Patients With ALK-Rearranged NSCLC
